Clinically, tumor tissue immunohistochemistry (IHC) staining is used to measure the protein expression of four transcription factors (ASCL1, NEUROD1, POU2F3, and YAP1) to identify SCLC subtypes. Here, ASCL1 is linked to neoplasm.